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Alterations in fuel homeostasis in adult male rats by perinatal poly-
unsaturated fatty acid supplementation are insulin-dependent 
Nyakas, C1,2, Kóbor-Nyakas, DÉ1, Jónás, I1,2, Heinsbroek, A2, Zsigri, S1,
van Dijk, G2
1Semmelweis University, Budapest, Hungary 
2Groningen University, Groningen, The Netherlands 
Maternal factors can have major imprinting effects on homeostatic 
mechanisms in the developing fetus and newborn. Here we studied 
whether supplemented perinatal poly-unsaturated fatty acids (PUFAs) 
influence energy balance and fuel homeostasis later in life. Between day 
10 after conception and day 10 after delivery, female rats were subjected 
to chow enriched with 10% fish-oil (FO-rich). Fish oil contains high 
concentration of n-3 biosynthesis endpoint products, which caused 
increased membrane phospholipid incorporation (particularly derived 
from the long-chain 20+:n-3 PUFAs) in pup brains. Adult male offspring 
of FO-rich fed rats had reduced body weight (-20%) at 3 months, and had 
lower levels of plasma leptin (-54%), insulin (-41%), triglycerides (-65%), 
and lactate (-46%) than controls. All differences between groups were lost 
48 hr after streptozotocin treatment, indicating that differences between 
control and FO-rich offspring depend on insulin action. At 4.5 months of 
age increased insulin sensitivity (following intraperitoneal injection) to 
lower blood glucose was found in FO-rich as compared to controls. We 
concluded that perinatal FO supplementation has lasting effects on body 
weight homeostasis and fuel metabolism in male offspring.  
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Background: The A-allele of FTO rs9939609 is associated with fatness. We aimed 
to investigate the impact of this variant on cross-sectional and longitudinal measures 
of BMI, height, and lean body mass.  
Methods: At up to eight points in time from birth to adulthood, anthropometric 
measures were available on 753 obese (BMI>31.0 kg/m2) and 879 randomly sampled 
non-obese men, originally identified at the Danish draft boards. Logistic regression 
was used to assess the odds for being a carrier of FTO rs9939609 according to 1) z-
scores for BMI, height and lean body mass (assessed by bioimpedance and DXA-
scan) at given time-points and 2) longitudinal changes in growth. 
Results: Except at birth, the AA genotype was associated with increased BMI z-
scores at any point during the monitored life span, starting at age 7. This effect 
remained stable until early adulthood (age 20), where homozygous individuals were 
predisposed for further weight gain. The AA genotype was further associated with 
accelerated linear growth in childhood (age 7; OR, 1.36; 95% CI, 1.06 – 1.74),
whereas final height was unaffected. Finally, individuals homozygous for the A 
allele had increased lean body mass (OR, 1.24; 95% CI, 1.02 – 1.32). These 
associations where only partly explained by the FTO-related obesity.  
Conclusion: The fatness induced by FTO rs9939609 in early childhood remains 
stable until early adulthood, where further weight gain may occur. Moreover, this 
obesity-promoting gene variant is associated with features of general growth (linear 
growth and lean body mass).   
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The anti-diabetic drug metformin exerts an anti-tumoral effect in 
vitro and in vivo through a decrease in cyclin D1 level 
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As a widely used anti-diabetic drug Metformin regulates glucose 
homeostasis and improves metabolic disorders associated with obesity. 
Recent studies suggest that metformin may reduce the risk of cancer, but 
its mode of action remains not elucidated. We investigated the effect of 
metformin on human prostate cancer cell proliferation in vitro and in vivo.
Metformin inhibited the proliferation of DU145, PC-3 and LNCaP cancer 
cells with a 50% decrease of cell viability and had a modest effect on 
normal prostate epithelial cell line P69. Metformin did not induce 
apoptosis but blocked cell cycle in G0/G1. This blockade was 
accompanied by a strong decrease in cyclin D1 protein level, pRb 
phosphorylation and an increase in p27kip protein expression. Although, 
metformin activated the AMP kinase pathway, a fuel sensor signalling 
pathway, this effect does not appear to be involved in its anti proliferative 
effect. Indeed, inhibition of the AMPK pathway using siRNA against the 
two catalytic units of AMPK did not prevent the effect of metformin in 
prostate cancer cells. Importantly, oral and intraperitoneal treatment of 
mice bearing xenografts of LNCaP with metformin led to a 50% and 35% 
reduction of tumor growth, respectively. Similarly, to the in vitro study, 
metformin led to a strong reduction of cyclin D1 protein level in tumors 
providing evidence for a mechanism that may contribute to the 
antineoplastic effects of metformin suggested by recent epidemiological 
studies. 
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Accumulating recent evidences propose that metastatic traits of breast cancer cells 
are acquired through exposure of tumour cells to paracrine signals that they receive 
from the tumour-associated stroma. Most of the studies on epithelial-stroma 
interactions during breast cancer cell invasion have focused on fibroblasts, 
endothelial and inflammatory cells. Very little attention has been given to adipocytes 
despite their abundance in breast stroma and their ability to secrete many adipokines 
potentially able to influence tumour behaviour. We show here using 2- and 3D 
culture systems that co-culture of breast tumour cells, either with low (ZR 75.1) or 
high (SUM159-PT) metastatic potential, with adipocytes increases their capacity to 
invade through Matrigel matrixes by 2 to 3-fold. This increased invasive capacity
was associated with an up-regulation of the CXCR-4 receptor, occurring at 
transcriptional level. Interestingly, this pro-invasive effect was not recapitulated 
when tumour cells were grown in the presence of adipocytes-conditioned medium, 
suggesting a cross talk between the two cell population. In fact, culture of adipocytes 
with breast tumour cells increases the levels of pro-inflammatory cytokines that in 
turn regulate the level of CXCR-4 expression. We are currently investigating the 
expression of these cytokines in either normal (isolated from mammoplasty) or 
peritumoral (isolated from tumorectomy) breast adipocytes. In conclusion, our 
results strongly suggest that peri-tumoral adipocytes cooperate with breast tumour 
cells to provide an invasive phenotype. In addition, these results might contribute to 
explain the poor prognosis of breast cancer in obese women  
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